The safety lancet market size has grown strongly in recent years. It will grow from $2.14 billion in 2025 to $2.34 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing prevalence of diabetes, growth in routine blood testing, rising awareness of healthcare worker safety, expansion of diagnostic laboratories, adoption of glucose monitoring programs.
The safety lancet market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth in home diagnostics, rising chronic disease burden, stricter occupational safety regulations, increasing preventive healthcare screening, expansion of point-of-care diagnostics. Major trends in the forecast period include rising adoption of safety-engineered blood collection devices, growing preference for single-use disposable lancets, increasing home-based diagnostic testing, enhanced focus on needlestick injury prevention, expansion of point-of-care testing applications.
The rising prevalence of diabetes is increasingly supporting the expansion of the safety lancet market going forward. Diabetes is a chronic medical condition that occurs when the body is unable to properly regulate blood glucose levels. The prevalence of diabetes continues to rise due to increasingly sedentary lifestyles, which contribute to higher obesity rates and insulin resistance across populations. Safety lancets are widely used in diabetes management to safely and conveniently obtain blood samples for glucose monitoring, while minimizing the risk of infection and needle-stick injuries. For example, in May 2024, according to the British Diabetic Association (Diabetes UK), a UK-based charitable organization, approximately 4.4 million people in the UK were living with diabetes, with type 1 diabetes accounting for around 8% of cases and type 2 diabetes comprising nearly 90%. Consequently, the growing prevalence of diabetes is strengthening demand for safety lancets.
Leading companies operating in the safety lancet market are developing innovative devices, such as heel lancets, to improve safety and accuracy in heel puncture procedures for infants. Heel lancets are sterile, single-use devices used to collect blood samples from the heel, commonly applied in newborn screening and glucose monitoring. For example, in October 2023, Owen Mumford, a UK-based medical solutions company, launched Unistik Heelstik neonatal and pediatric capillary blood sampling devices. These devices incorporate advanced safety features that ensure precise punctures, minimize infant discomfort, and reduce the risk of needlestick injuries for healthcare professionals.
In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical devices company, acquired the pen needle and blood glucose monitoring business from Ypsomed Holding AG. With this acquisition, MTD aims to expand its diabetes care portfolio, strengthen its position in the global insulin delivery and monitoring market, and integrate Ypsomed’s established product lines to deliver comprehensive diabetes management solutions. Ypsomed Holding AG is a Switzerland-based manufacturer of medical devices and diabetes care products, including safety lancets.
Major companies operating in the safety lancet market are McKesson Corporation, Cardinal Health Inc., F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medline Industries Inc., Becton Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Nipro Corporation, Sarstedt AG & Co. KG., Greiner Bio-One International GmbH, Ypsomed Holding AG, Improve Medical Technology Co. Ltd, Omron Healthcare Inc., Owen Mumford Ltd., Arkray Inc., AgaMatrix Inc., Narang Medical Limited., DarioHealth Corp, HTL-STREFA S.A., Ribbel International Limited, Simple Diagnostics Inc., Sara Healthcare Private Limited, Smiths Medical, Sterimed Group.
North America was the largest region in the safety lancet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety lancet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the safety lancet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have moderately impacted the safety lancet market by increasing the cost of imported medical-grade plastics, needles, and automated assembly components, leading to higher production expenses for manufacturers. Regions with strong dependence on imports, particularly Asia-Pacific and parts of Latin America, are more affected, especially in disposable and pressure-activated lancet segments. However, tariffs have encouraged local manufacturing, supplier diversification, and cost-optimized product designs, supporting long-term supply chain resilience and regional production capabilities.
The safety lancet market research report is one of a series of new reports that provides safety lancet market statistics, including safety lancet industry global market size, regional shares, competitors with a safety lancet market share, detailed safety lancet market segments, market trends and opportunities, and any further data you may need to thrive in the safety lancet industry. This safety lancet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A safety lancet is a single-use medical device designed for blood sampling. It contains a sterile, spring-activated needle or blade that retracts automatically after puncture to reduce accidental needlestick injuries and cross-contamination, and is often used for procedures like blood glucose testing where small, controlled samples are required.
The primary product types of safety lancets include push-button safety lancets, pressure-activated safety lancets, and side-button safety lancets. Push-button safety lancets are blood-sampling devices equipped with a button-activated mechanism that safely deploys a needle to puncture the skin for glucose monitoring and other diagnostic blood tests. The applications include blood glucose testing, hemoglobin testing, and cholesterol testing and are used by end users such as hospitals and clinics, diagnostic centers and pathology laboratories, and home diagnostic settings.
The safety lancet market consists of sales of needle-free safety lancets, and specialized infant and pediatric safety lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The safety lancet market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growth in home diagnostics, rising chronic disease burden, stricter occupational safety regulations, increasing preventive healthcare screening, expansion of point-of-care diagnostics. Major trends in the forecast period include rising adoption of safety-engineered blood collection devices, growing preference for single-use disposable lancets, increasing home-based diagnostic testing, enhanced focus on needlestick injury prevention, expansion of point-of-care testing applications.
The rising prevalence of diabetes is increasingly supporting the expansion of the safety lancet market going forward. Diabetes is a chronic medical condition that occurs when the body is unable to properly regulate blood glucose levels. The prevalence of diabetes continues to rise due to increasingly sedentary lifestyles, which contribute to higher obesity rates and insulin resistance across populations. Safety lancets are widely used in diabetes management to safely and conveniently obtain blood samples for glucose monitoring, while minimizing the risk of infection and needle-stick injuries. For example, in May 2024, according to the British Diabetic Association (Diabetes UK), a UK-based charitable organization, approximately 4.4 million people in the UK were living with diabetes, with type 1 diabetes accounting for around 8% of cases and type 2 diabetes comprising nearly 90%. Consequently, the growing prevalence of diabetes is strengthening demand for safety lancets.
Leading companies operating in the safety lancet market are developing innovative devices, such as heel lancets, to improve safety and accuracy in heel puncture procedures for infants. Heel lancets are sterile, single-use devices used to collect blood samples from the heel, commonly applied in newborn screening and glucose monitoring. For example, in October 2023, Owen Mumford, a UK-based medical solutions company, launched Unistik Heelstik neonatal and pediatric capillary blood sampling devices. These devices incorporate advanced safety features that ensure precise punctures, minimize infant discomfort, and reduce the risk of needlestick injuries for healthcare professionals.
In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical devices company, acquired the pen needle and blood glucose monitoring business from Ypsomed Holding AG. With this acquisition, MTD aims to expand its diabetes care portfolio, strengthen its position in the global insulin delivery and monitoring market, and integrate Ypsomed’s established product lines to deliver comprehensive diabetes management solutions. Ypsomed Holding AG is a Switzerland-based manufacturer of medical devices and diabetes care products, including safety lancets.
Major companies operating in the safety lancet market are McKesson Corporation, Cardinal Health Inc., F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medline Industries Inc., Becton Dickinson and Company, B. Braun SE, Terumo Medical Corporation, Nipro Corporation, Sarstedt AG & Co. KG., Greiner Bio-One International GmbH, Ypsomed Holding AG, Improve Medical Technology Co. Ltd, Omron Healthcare Inc., Owen Mumford Ltd., Arkray Inc., AgaMatrix Inc., Narang Medical Limited., DarioHealth Corp, HTL-STREFA S.A., Ribbel International Limited, Simple Diagnostics Inc., Sara Healthcare Private Limited, Smiths Medical, Sterimed Group.
North America was the largest region in the safety lancet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the safety lancet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the safety lancet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have moderately impacted the safety lancet market by increasing the cost of imported medical-grade plastics, needles, and automated assembly components, leading to higher production expenses for manufacturers. Regions with strong dependence on imports, particularly Asia-Pacific and parts of Latin America, are more affected, especially in disposable and pressure-activated lancet segments. However, tariffs have encouraged local manufacturing, supplier diversification, and cost-optimized product designs, supporting long-term supply chain resilience and regional production capabilities.
The safety lancet market research report is one of a series of new reports that provides safety lancet market statistics, including safety lancet industry global market size, regional shares, competitors with a safety lancet market share, detailed safety lancet market segments, market trends and opportunities, and any further data you may need to thrive in the safety lancet industry. This safety lancet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A safety lancet is a single-use medical device designed for blood sampling. It contains a sterile, spring-activated needle or blade that retracts automatically after puncture to reduce accidental needlestick injuries and cross-contamination, and is often used for procedures like blood glucose testing where small, controlled samples are required.
The primary product types of safety lancets include push-button safety lancets, pressure-activated safety lancets, and side-button safety lancets. Push-button safety lancets are blood-sampling devices equipped with a button-activated mechanism that safely deploys a needle to puncture the skin for glucose monitoring and other diagnostic blood tests. The applications include blood glucose testing, hemoglobin testing, and cholesterol testing and are used by end users such as hospitals and clinics, diagnostic centers and pathology laboratories, and home diagnostic settings.
The safety lancet market consists of sales of needle-free safety lancets, and specialized infant and pediatric safety lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Safety Lancet Market Characteristics
3. Safety Lancet Market Supply Chain Analysis
4. Global Safety Lancet Market Trends and Strategies
5. Safety Lancet Market Analysis of End Use Industries
7. Global Safety Lancet Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Safety Lancet Total Addressable Market (TAM) Analysis for the Market
9. Safety Lancet Market Segmentation
10. Safety Lancet Market Regional and Country Analysis
11. Asia-Pacific Safety Lancet Market
12. China Safety Lancet Market
13. India Safety Lancet Market
14. Japan Safety Lancet Market
15. Australia Safety Lancet Market
16. Indonesia Safety Lancet Market
17. South Korea Safety Lancet Market
18. Taiwan Safety Lancet Market
19. South East Asia Safety Lancet Market
20. Western Europe Safety Lancet Market
21. UK Safety Lancet Market
22. Germany Safety Lancet Market
23. France Safety Lancet Market
24. Italy Safety Lancet Market
25. Spain Safety Lancet Market
26. Eastern Europe Safety Lancet Market
27. Russia Safety Lancet Market
28. North America Safety Lancet Market
29. USA Safety Lancet Market
30. Canada Safety Lancet Market
31. South America Safety Lancet Market
32. Brazil Safety Lancet Market
33. Middle East Safety Lancet Market
34. Africa Safety Lancet Market
36. Safety Lancet Market Competitive Landscape and Company Profiles
37. Safety Lancet Market Other Major and Innovative Companies
40. Safety Lancet Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Safety Lancet Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses safety lancet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for safety lancet? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The safety lancet market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Push Button Safety Lancet; Pressure Activated Safety Lancet; Side Button Safety Lancet2) By Application: Blood Glucose Testing; Hemoglobin Testing; Cholesterol Testing; Coagulation Testing
3) By End-User: Hospitals And Clinics; Diagnostic Centers And Pathology Laboratories; Home Diagnostics; Other End-Users
Subsegments:
1) By Push Button Safety Lancet: Manual Push Button Safety Lancets; Automatic Push Button Safety Lancets; Adjustable Depth Push Button Safety Lancets2) By Pressure Activated Safety Lancet: Single-Use Pressure Activated Lancets; Multi-Use Pressure Activated Lancets; Adjustable Pressure Activated Lancets
3) By Side Button Safety Lancet: Standard Side Button Safety Lancets; Ergonomic Side Button Safety Lancets; Adjustable Depth Side Button Safety Lancets
Companies Mentioned: McKesson Corporation; Cardinal Health Inc.; F. Hoffmann-La Roche AG; Bayer AG; Abbott Laboratories; Medline Industries Inc.; Becton Dickinson and Company; B. Braun SE; Terumo Medical Corporation; Nipro Corporation; Sarstedt AG & Co. KG.; Greiner Bio-One International GmbH; Ypsomed Holding AG; Improve Medical Technology Co. Ltd; Omron Healthcare Inc.; Owen Mumford Ltd.; Arkray Inc.; AgaMatrix Inc.; Narang Medical Limited.; DarioHealth Corp; HTL-STREFA S.A.; Ribbel International Limited; Simple Diagnostics Inc.; Sara Healthcare Private Limited; Smiths Medical; Sterimed Group
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Safety Lancet market report include:- McKesson Corporation
- Cardinal Health Inc.
- F. Hoffmann-La Roche AG
- Bayer AG
- Abbott Laboratories
- Medline Industries Inc.
- Becton Dickinson and Company
- B. Braun SE
- Terumo Medical Corporation
- Nipro Corporation
- Sarstedt AG & Co. KG.
- Greiner Bio-One International GmbH
- Ypsomed Holding AG
- Improve Medical Technology Co. Ltd
- Omron Healthcare Inc.
- Owen Mumford Ltd.
- Arkray Inc.
- AgaMatrix Inc.
- Narang Medical Limited.
- DarioHealth Corp
- HTL-STREFA S.A.
- Ribbel International Limited
- Simple Diagnostics Inc.
- Sara Healthcare Private Limited
- Smiths Medical
- Sterimed Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.34 Billion |
| Forecasted Market Value ( USD | $ 3.3 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
